Browse by Creator

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping | Creators | Date
Number of items: 4.

Article

Burns, A., McCaddon, A., Thomas, A., Ballard, C., Jacova, C., Richie, C., Wilkinson, D., Ford, G., Feldman, H., O'Brien, J., Warner, J., Orgogozo, J., Broich, K., Knapp, M., McKeith, M., Richardson, M., Purandare, N., Bullock, R., Jones, R., Auriacombe, S., Lennon, S., Lliffe, S. and Wilcock, G. (2006) Clinical practice with anti-dementia drugs: A consensus statement from British Association for Psychopharmacology. Journal of Psychopharmacology , 20 (6). pp. 732-755. ISSN 0269-8811

Bayer, A. J., Wilkinson, D., Paterson, K. R., Jenkins, L., Bullock, R., Donoghue, S., Millais, S. B. and Jones, R. (2005) Evaluation of the safety and immunogenicity of synthetic Aβ42 (AN1792) in patients with AD. Neurology, 64 (1). pp. 94-101. ISSN 0028-3878

H, C., Howe, I., Truyen, L., Bullock, R., Lilienfield, S., Zhu, Y. and Wilcock, G. (2003) A Long-Term Comparison of Galantamine and Donepezil in the Treatment of Alzheimer s Disease. Drugs and Aging, 20 (10). pp. 777-789.

Conference or Workshop Item

Soininen, H., Martin, S., Bullock, R., Alhainen, K., Hager, K., Jones, R., Aarsland, D., Murthy, A., Zhang, R. and Bahra, R. (2002) First head to head study comparing the efficacy of donepezil and galantamine in Alzheimer's disease. In: 15th Congress of the European College of Neuropsychopharmacology, Barcelona, Spain, 5 October 2002.

This list was generated on Sat Nov 1 03:58:50 2014 GMT.
Copyright 2013 © UWE better together